Received Apr 11, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| DTAPIPV | DTAP + IPV (QUADRACEL) | SANOFI PASTEUR | 5 | U79088A | IM / RL |
| MMR | MEASLES + MUMPS + RUBELLA (MMR II) | MERCK & CO. INC. | 2 | Y009782 | SC / RL |
| VARCEL | VARICELLA (VARIVAX) | MERCK & CO. INC. | 2 | Y017061 | SC / LL |
Moderate to severe injection site reaction over anterior R thigh, 10 - 12 cm in greatest dimension. Developed in first 24 hours. No systemic sx noted. Advised cool compresses, Tylenol / Motrin PRN, and OTC topical 1% HC for itching PRN. Discussed signs of anaphylaxis, reasons to seek emergency care.
No acute illness at time of vaccination. Influenza A diagnosed about 3 weeks prior.
None
NKDA